SORAFENIB (S) plus GEMCITABINE/CISPLATIN (GC) VS GC ALONE IN THE FIRST-LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): PHASE III NSCLC RESEARCH EXPERIENCE UTILIZING SORAFENIB (NEXUS) TRIAL
ANNALS OF ONCOLOGY（2010）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要